Spotlight
Clinical Role
Clinical
Supplement Spotlight
CME/CE
Subscribe
Managing Adverse Events Associated with HE Therapies
Ralph J. Riello, PharmD, BCPS, discusses the adverse events associated with hepatic encephalopathy (HE) treatments and the importance of encouraging patients to continue first-line medications despite adverse reactions to prevent HE recurrence.
EP: 1.Identifying and Screening for Hepatic Encephalopathy Risk Factors
EP: 2.Achieving Post-Discharge Success: Goals in Hepatic Encephalopathy Care
EP: 3.Implementing Evidence-Based Guidelines for Hepatic Encephalopathy Management
EP: 4.Addressing the Caregiver Burden in Hepatic Encephalopathy Management
EP: 5.Optimizing Care for Newly Diagnosed Hepatic Encephalopathy
EP: 6.Enhancing Hepatic Encephalopathy Care through Pharmacist-Prescriber Collaboration
Now Viewing
EP: 7.Managing Adverse Events Associated with HE Therapies
EP: 8.Integrating Treatment Protocols and Community Pharmacy in HE Management
EP: 9.Promoting Adherence: Strategies for Maintaining HE Therapy
EP: 10.Empowering Pharmacists: Essential Insights for HE Management
EP: 11.Optimizing Transitions of Care for Hepatic Encephalopathy Patients
EP: 12.Collaborative Care: Key Stakeholders in HE Treatment and Recovery
EP: 13.Hepatic Encephalopathy: Critical Insights and Closing Thoughts
Recent Videos
Related Content
